| Aug 30 |
Astria Therapeutics to Present at Upcoming Bradykinin Symposium
|
| Aug 29 |
Astria Therapeutics to Participate in Upcoming Morgan Stanley 22nd Annual Global Healthcare Conference
|
| Aug 12 |
Astria Therapeutics GAAP EPS of -$0.43 misses by $0.03
|
| Aug 12 |
Astria Therapeutics Reports Second Quarter 2024 Financial Results and Provides a Corporate Update
|
| Aug 12 |
Astria Therapeutics Chooses Ypsomed’s YpsoMate as the Injection Device for STAR-0215 for the Treatment of Hereditary Angioedema
|
| Aug 7 |
Astria Therapeutics to Participate in Upcoming 2024 Wedbush PacGrow Healthcare Conference
|
| Jun 24 |
Astria Therapeutics: A Cash-Rich Entrant In An Increasingly Crowded Field
|
| Jun 4 |
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
| May 30 |
Astria Therapeutics to Present at Upcoming Jefferies Healthcare Conference
|
| May 24 |
Astria Therapeutics to Present at Upcoming Eastern Allergy Conference
|
